Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419400
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2024-05-14
Brief Title:
A Research Study to Explore the Impact of GP Support Via Text Messages to Patients With Asthma andor COPD
Sponsor:
Accurx
Organization:
Accurx
Study Overview
Official Title:
A Randomised Controlled Trial to Evaluate the Impact of Supportive Text Messages From GP Practices on Self-reported Symptoms and Inhaler Adherence in Patients With Asthma andor Chronic Obstructive Pulmonary Disease COPD Who Have Been Prescribed a Preventer Daily Inhaler Inhaler Trial
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A 6-month randomised controlled trial to evaluate the impact of text message support on symptom control and inhaler adherence for patients with asthma andor COPD
Detailed Description:
This trial will be a 6-month prospective randomised controlled trial in which the study population is randomly allocated 11 to an intervention or control group The trial is multicentre and is non-blind All patients in both groups will continue to receive their usual care for the duration of the study Randomisation will be at the individual level Participants will be randomly allocated as per a computer-generated randomisation list using a random number generator as part of the Microsoft NET framework
This is a behavioural intervention The intervention will consist of a series of supportive text messages to patients from their GP practice over a 6 month period The messages will vary in frequency from 2 or 3 in the first weeks of the trial to only 1 or 2 a month in the final months of the trial The content of the messages will vary some will contain information about how to use a preventer inhaler some will emphasise the importance of using it and some will provide simple reminders to patients to take their inhaler
All participants will continue to receive their usual care throughout the duration of the study the text message intervention with be in addition to their usual care
This is a behavioural intervention The intervention will consist of a series of supportive text messages to patients from their GP practice over a 6 month period The messages will vary in frequency from 2 or 3 in the first weeks of the trial to only 1 or 2 a month in the final months of the trial The content of the messages will vary some will contain information about how to use a preventer inhaler some will emphasise the importance of using it and some will provide simple reminders to patients to take their inhaler
All participants will continue to receive their usual care throughout the duration of the study the text message intervention with be in addition to their usual care
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None